Target
$24.60 → $24.33
Current stock research snapshot · 7/31/26 26 days old
RLAYRelay Therapeutics
Investment conviction●●○○○2 of 5 · current snapshot
Research target$24.33Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 7/31/26
Market cap$4.00BSnapshot value · 7/31/26
Research history
See all RLAY changes ↗What changed
Healthspan taxonomy seed — see taxonomy_path
Relay Therapeutics Q2 2026 earnings; RLY-2608 (PI3Ka) breast cancer trial data; mutation-agnostic strategy validation; discovery pipeline progress
needs primary source validation — pending deep-dive research. Placeholder: (1) thesis chain breaks on primary-source evidence, (2) named revenue/customer concentration risk, (3) margin compression or competitive displacement
Neutral — No investor-style discussion found. [X search Aug 2026]
Snapshot · 7/31/26🟡 Mixed · ins-$7.8M · 13F 18+/4-×0.5 · short↓0.31
Snapshot · 7/31/26